The U.S. FDA announced this week that it deployed a generative AI tool called ELSA, now in use by staff across the agency, several weeks ahead of its original schedule.

The U.S. Food and Drug Administration said on Monday that it had launched a generative AI tool, Elsa, aimed at improving efficiency across its operations, including scientific reviews. "Today's rollout of Elsa is ahead of schedule and under budget,

Dubbed Elsa, the tool was expected to roll out at the end of June. The FDA says it marks the dawn of a new era.